Z-3244-2018 Class II Terminated

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-3244-2018 was initiated by Tosoh Bioscience Inc on Jul 13, 2018 and is designated Class II. Reason for recall: Analyzers were distributed with software which lacks a 510K The recall status is terminated (terminated Jul 8, 2020). Affected quantity: 8 units.

Recall details

Product Type
Devices
Report Date
Oct 3, 2018
Initiation Date
Jul 13, 2018
Termination Date
Jul 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8 units

Product description

G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.

Reason for recall

Analyzers were distributed with software which lacks a 510K

Distribution pattern

US Nationwide Distribution in states of - CA, OK, VA 7 WI

Code information

Serial Numbers: 14646304, 14917201, 14886112, 14616503, 14856212, 14887601, 14886212 & 14917201

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-3244-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-3244-2018. Report a data issue: hello@regdatalab.com.